BB Biotech AG (BION.SW)
BB Biotech AG operates in the Asset Management industry of the Financial Services sector, headquartered in Kusnacht, CH. The stock last traded at $53.90, up 0.75% on the session, giving a market capitalisation of $2.97B. Its beta of 0.93 implies it has historically moved less than the broad market.
BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is headquartered in Switzerland.
BB Biotech AG is most often compared with the following Financial Services names: